{"entity":{"type":"insider","cik":"0001783583","url":"/insider/0001783583","json_url":"/insider/0001783583.json","name":"Pillar Partners Foundation, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":8,"first":"2019-11-08","last":"2023-07-19","span_basis":"filed_date"},"name_variants":[{"name":"Pillar Partners Foundation, L.P.","source":"filing","n_filings":8,"first_seen":"2019-11-08","last_seen":"2023-07-19"}],"transactions":[{"id":8388743,"accession":"0000899243-23-017445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-017445","line_url":"/filing/0000899243-23-017445#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"Aceragen, Inc.","issuer_ticker":"ACGN","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Partners Foundation, L.P.; Umari Abude; ZEIN YOUSSEF EL; Pillar Invest Corp; Pillar Pharmaceuticals 6, L.P.","owner_display_name":"Pillar Partners Foundation, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2213.0,"shares_display":"2,213","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":3408.02,"total_display":"3,408.02","total_whole":"3,408","shares_owned_after":164894.0,"shares_owned_after_display":"164,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-19","scope":"insider"},{"id":8388738,"accession":"0000899243-23-017445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-017445","line_url":"/filing/0000899243-23-017445#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"Aceragen, Inc.","issuer_ticker":"ACGN","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Partners Foundation, L.P.; Umari Abude; ZEIN YOUSSEF EL; Pillar Invest Corp; Pillar Pharmaceuticals 6, L.P.","owner_display_name":"Pillar Partners Foundation, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3605.0,"shares_display":"3,605","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":5695.9,"total_display":"5,695.90","total_whole":"5,696","shares_owned_after":167107.0,"shares_owned_after_display":"167,107","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-19","scope":"insider"},{"id":8620297,"accession":"0000899243-23-017446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-017446","line_url":"/filing/0000899243-23-017446#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"Aceragen, Inc.","issuer_ticker":"ACGN","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Umari Abude; Pillar Invest Corp; Pillar Pharmaceuticals 6, L.P.","owner_display_name":"Pillar Partners Foundation, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26965.0,"shares_display":"26,965","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":38290.3,"total_display":"38,290.30","total_whole":"38,290","shares_owned_after":170712.0,"shares_owned_after_display":"170,712","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-07-19","scope":"insider"},{"id":4508544,"accession":"0000899243-21-014303","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-014303","line_url":"/filing/0000899243-21-014303","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Partners Foundation, L.P.; Umari Abude; ZEIN YOUSSEF EL; Pillar Pharmaceuticals 6, L.P.; Pillar Invest Corp","owner_display_name":"Pillar Partners Foundation, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1699765.0,"shares_display":"1,699,765","price_per_share":1.7985,"price_display":"1.80","price_state":"stated","total_value":3057027.3525,"total_display":"3,057,027.35","total_whole":"3,057,027","shares_owned_after":4121599.0,"shares_owned_after_display":"4,121,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-18","filed_date":"2021-03-31","scope":"insider","n_lines":2},{"id":3075949,"accession":"0000899243-20-033917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-033917","line_url":"/filing/0000899243-20-033917#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"ZEIN YOUSSEF EL; Pillar Invest Corp; Umari Abude; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals 6, L.P.","owner_display_name":"ZEIN YOUSSEF EL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69941.0,"shares_display":"69,941","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":127292.62,"total_display":"127,292.62","total_whole":"127,293","shares_owned_after":5497638.0,"shares_owned_after_display":"5,497,638","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-15","scope":"insider"},{"id":3309929,"accession":"0000899243-20-019207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-019207","line_url":"/filing/0000899243-20-019207#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Umari Abude; Pillar Partners Foundation, L.P.; Pillar Invest Corp; ZEIN YOUSSEF EL","owner_display_name":"Umari Abude","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":749993.0,"shares_display":"749,993","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":1289987.96,"total_display":"1,289,987.96","total_whole":"1,289,988","shares_owned_after":5427697.0,"shares_owned_after_display":"5,427,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-15","scope":"insider"},{"id":2418358,"accession":"0000899243-20-010617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-010617","line_url":"/filing/0000899243-20-010617#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"ZEIN YOUSSEF EL; Pillar Partners Foundation, L.P.; Pillar Invest Corp; Umari Abude","owner_display_name":"ZEIN YOUSSEF EL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3039514.0,"shares_display":"3,039,514","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":4620061.28,"total_display":"4,620,061.28","total_whole":"4,620,061","shares_owned_after":6260832.0,"shares_owned_after_display":"6,260,832","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-07","filed_date":"2020-04-09","scope":"insider"},{"id":2592244,"accession":"0000899243-20-005917","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17250.0,"shares_display":"17,250","price_per_share":1.7645,"price_display":"1.76","price_state":"stated","total_value":30437.625,"total_display":"30,437.62","total_whole":"30,438","shares_owned_after":3254442.0,"shares_owned_after_display":"3,254,442","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-29","filed_date":"2020-02-26","scope":"insider"},{"id":2592238,"accession":"0000899243-20-005917","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12532.0,"shares_display":"12,532","price_per_share":1.762,"price_display":"1.76","price_state":"stated","total_value":22081.384,"total_display":"22,081.38","total_whole":"22,081","shares_owned_after":3271692.0,"shares_owned_after_display":"3,271,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-28","filed_date":"2020-02-26","scope":"insider"},{"id":2592235,"accession":"0000899243-20-005917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":26550.0,"total_display":"26,550.00","total_whole":"26,550","shares_owned_after":3284224.0,"shares_owned_after_display":"3,284,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-02-26","scope":"insider"},{"id":7909824,"accession":"0000899243-19-027012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":21960.0,"total_display":"21,960.00","total_whole":"21,960","shares_owned_after":3299224.0,"shares_owned_after_display":"3,299,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-08","scope":"insider"},{"id":7909821,"accession":"0000899243-19-027012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":3308224.0,"shares_owned_after_display":"3,308,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-07","filed_date":"2019-11-08","scope":"insider"},{"id":7909818,"accession":"0000899243-19-027012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":2.4956,"price_display":"2.50","price_state":"stated","total_value":249560.0,"total_display":"249,560.00","total_whole":"249,560","shares_owned_after":3318224.0,"shares_owned_after_display":"3,318,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-06","filed_date":"2019-11-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"Aceragen, Inc.","url":"/issuer/0000861838","role":"Ten percent owner","n_filings":8,"first_seen":"2019-11-08","last_seen":"2023-07-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001783583","retrieved_at":"2026-08-23T04:21:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}